The study by Ricci et al. examined the activity of MMP-2 and MMP-9 in the sera of brain tumor patients (gliomas, meningiomas, and metastases) compared to healthy controls using zymography and immunohistochemistry. The gene discussed is MMP9; the disease is brain neoplasm.